Skip to main content
SpringerLink
Log in

Oncogenomics/Proteomics of Head and Neck Cancers

  • Chapter
  • First Online:
Head and Neck Cancer

  • 2430 Accesses

Abstract

Over the past 20 years, we have seen a rapid development in our understanding of the molecular mechanisms of head and neck squamous cell cancer (HNSCC). These discoveries are in large part the result of advances in technology. Here, we first review the major technologies in both oncogenomics and proteomics as they apply to HNSCC and then review the results of seminal studies. These data lay the foundation for the next decade of discovery in HNSCC and are relevant to the clinician and scientist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456(7218):53–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cohen EEW, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, et al. A feed-forward loop involving protein kinase Cα and microRNAs regulates tumor cell cycle. Cancer Res. 2009;69:65–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene. 2008;27:6607–22.

    Article  CAS  PubMed  Google Scholar 

  4. Thurlow JK, Murillo CLP, Hunter KD, Buffa FM, Patiar S, Betts G, et al. Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J Clin Oncol. 2010;28:2881–8.

    Article  CAS  PubMed  Google Scholar 

  5. Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res. 2006;66:8210–8.

    Article  CAS  PubMed  Google Scholar 

  6. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004;5:489–500.

    Article  CAS  PubMed  Google Scholar 

  7. Walter V, Yin X, Wilkerson MD, Cabanski CR, Zhao N, Du Y, et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One. 2013;8(2), e56823.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Collins FS. The Cancer Genome Atlas (TCGA). Online. 2007;1–17.

    Google Scholar 

  9. Toruner GA, Ulger C, Alkan M, Galante AT, Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN, et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet. 2004;154(1):27–35.

    Article  CAS  PubMed  Google Scholar 

  10. Ye H, Yu T, Temam S, Ziober BL, Wang J, Schwartz JL, Mao L, Wong DT, Zhou X. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics. 2008;9:69.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et al. Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 2004;61(11):1372–83.

    Article  CAS  PubMed  Google Scholar 

  12. Sticht C, Freier K, Knopfle K, Flechtenmacher C, Pungs S, Hofele C, Hahn M, Joos S, Lichter P. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia. 2008;10(5):462–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007;67(10):4605–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ha PK, Benoit NE, Yochem R, Sciubba J, Zahurak M, Sidransky D, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res. 2003;9(8):3058–64.

    CAS  PubMed  Google Scholar 

  15. Chen C, Méndez E, Houck J, Fan W, Lohavanichbutr P, Doody D, et al. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:2152–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004;64:55–63.

    Article  CAS  PubMed  Google Scholar 

  17. Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, Feldman MM, et al. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res. 2006;12:5960–71.

    Article  CAS  PubMed  Google Scholar 

  18. Kondoh N, Ohkura S, Arai M, Hada A, Ishikawa T, Yamazaki Y, et al. Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma. Oral Oncol. 2007;43:455–62.

    Article  CAS  PubMed  Google Scholar 

  19. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. International Cancer Genome Consortium [Internet]. ICGC Cancer Genome Projects. 2014. https://icgc.org/. Accessed 22 Dec 2014.

  22. Howell GMS, Grandis JR. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck. 2005;27(8):710–7.

    Article  PubMed  Google Scholar 

  23. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:295–302.

    Article  PubMed  Google Scholar 

  24. Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2005;131:10–8.

    Article  PubMed  Google Scholar 

  25. Roepman P, Wessels LFA, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005;37:182–6.

    Article  CAS  PubMed  Google Scholar 

  26. Hensen EF, De Herdt MJ, Goeman JJ, Oosting J, Smit VT, Cornelisse CJ, et al. Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: a pathway-based analysis. BMC Cancer. 2008;8:168.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene. 2004;23:2484–98.

    Article  CAS  PubMed  Google Scholar 

  28. Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, et al. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA. 2007;297:187–95.

    Article  CAS  PubMed  Google Scholar 

  29. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One. 2011;6(1), e16466.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, et al. TMEM16A, induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012;72:3270–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Shiwarski DJ, Shao C, Bill A, Kim J, Xiao D, Bertrand C, et al. To “grow” or “go”: TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clin Cancer Res. 2014;20(17):4673–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ishigami T, Uzawa K, Higo M, Nomura H, Saito K, Kato Y, et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer. 2007;120:2262–70.

    Article  CAS  PubMed  Google Scholar 

  33. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res. 2005;65:7169–76.

    Article  CAS  PubMed  Google Scholar 

  34. Akervall J, Nandalur S, Zhang J, Qian C-N, Goldstein N, Gyllerup P, et al. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Eur J Cancer. 2014;50(3):570–81.

    Article  CAS  PubMed  Google Scholar 

  35. Pramana J, Van den Brekel MWM, van Velthuysen M-LF, Wessels LFA, Nuyten DS, Hofland I, et al. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(5):1544–52.

    Article  CAS  PubMed  Google Scholar 

  36. Ganly I, Talbot S, Carlson D, Viale A, Maghami E, Osman I, et al. Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma. J Clin Oncol. 2007;25:1369–76.

    Article  CAS  PubMed  Google Scholar 

  37. Olaussen KA, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006;355(10):983–91.

    Article  CAS  PubMed  Google Scholar 

  38. Bauman JE, Austin MC, Schmidt R, Kurland BF, Vaezi A, Hayes DN, et al. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer. 2013;109(8):2096–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Roh J-L, Kim EH, Park HB, Park JY. The Hsp90 inhibitor 17-(allylamino)-17-demethoxygeldanamycin increases cisplatin antitumor activity by inducing p53-mediated apoptosis in head and neck cancer. Cell Death Dis. 2013;4(12), e956.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Li Y, St. John MAR, Zhou X, Kim Y, Sinha U, Jordan RCK, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10:8442–50.

    Article  CAS  PubMed  Google Scholar 

  41. Li Y, Elashoff D, Oh M, Sinha U, St John MAR, Zhou X, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol. 2006;24:1754–60.

    Article  CAS  PubMed  Google Scholar 

  42. John K, Wu J, Lee B, Farah CS. MicroRNAs in head and neck cancer. Int J Dent. 2013;2013:650218. doi:10.1155/2013/650218.

    Google Scholar 

  43. Davalos V, Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol. 2010;22:35–45.

    Article  CAS  PubMed  Google Scholar 

  44. Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cell Oncol (Dordr). 2013;36(1):1–7.

    Article  CAS  Google Scholar 

  45. Salazar C, Nagadia R, Pandit P, Cooper-White J, Banerjee N, Dimitrova N, et al. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol (Dordr). 2014;37(5):331–8.

    Article  CAS  Google Scholar 

  46. Ahn SM, Chan JYK, Zhang Z, Wang H, Khan Z, Bishop JA, et al. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(9):846–54.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer. 2005;104:1113–28.

    Article  CAS  PubMed  Google Scholar 

  48. Yu Y-H, Kuo H-K, Chang K-W. The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS One. 2008;3, e3215.

    Article  PubMed  PubMed Central  Google Scholar 

  49. De Cecco L, Bossi P, Locati L, Canevari S, Licitra L. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor. Ann Oncol. 2014;25(8):1628–35.

    Article  PubMed  Google Scholar 

  50. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res. 2004;10:4806–12.

    Article  CAS  PubMed  Google Scholar 

  51. Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, Warnken U, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene. 2007;26:54–64.

    Article  CAS  PubMed  Google Scholar 

  52. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC, et al. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope. 2008;118:61–8.

    Article  CAS  PubMed  Google Scholar 

  53. Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Datta Gupta S, et al. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics. 2008;7:1162–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Gourin CG, Zhi W, Adam B-L. Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope. 2009;119:1291–302.

    Article  CAS  PubMed  Google Scholar 

  55. Choi P, Jordan CD, Mendez E, Houck J, Yueh B, Farwell DG, et al. Examination of oral cancer biomarkers by tissue microarray analysis. Arch Otolaryngol Head Neck Surg. 2008;134:539–46.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Psyrri A, Lee J-W, Pectasides E, Vassilakopoulou M, Kosmidis EK, Burtness BA, et al. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303. Clin Cancer Res. 2014;20(11):3023–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Sidransky D, Sidransky D, Irizarry R, Califano JA, Li X, Ren H, et al. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J Natl Cancer Inst. 2003;95:1711–7.

    Article  CAS  PubMed  Google Scholar 

  58. Wadsworth JT, Somers KD, Stack Jr BC, Cazares L, Malik G, Adam BL, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg. 2004;130:98–104.

    Article  PubMed  Google Scholar 

  59. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14:6246–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol. 2007;30:743–9.

    CAS  PubMed  Google Scholar 

  61. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929–35.

    Article  PubMed  Google Scholar 

  62. Chai YD, Zhang L, Yang Y, Su T, et al. Discovery of potential serum protein biomarkers for lymph-node metastasis in oral cancer. Head Neck. 2016;38:118–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology – Head and Neck Surgery, Boston University School of Medicine, Veterans Administration Boston Health Care System, Boston, MA, USA

    Jason I. Kass MD, PhD

  2. Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center Albert Einstein College of Medicine Bronx, New York, NY, USA

    Howard S. Moskowitz MD, PhD

  3. University of California, San Francisco, Box 0558, 550 16th Street, 6th Floor, San Francisco, CA, 94143, USA

    Jennifer R. Grandis MD

Authors
  1. Jason I. Kass MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Howard S. Moskowitz MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer R. Grandis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer R. Grandis MD .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kass, J.I., Moskowitz, H.S., Grandis, J.R. (2016). Oncogenomics/Proteomics of Head and Neck Cancers. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation